9937 ISTH Gene Therapy Lentivirus Podcast Evaluation

3. What is your role in the care of individuals with hemophilia? Select all that apply *This question is required.

• Physician involved in direct patient care (management and monitoring of bleeding risk)
• Investigator in clinical trials of patients with hemophilia
• Perform assays/assessments in a specialized coagulation laboratory
• Physical, occupational, and/or mental health therapy
• Basic research related to hemophilia, but not related to patient care
• Patient education
• Other - specify Please enter an 'other' value for this selection.

6. Please rate your KNOWLEDGE of the use of lentivirus vectors for hemophilia gene therapy: *This question is required.

Space Cell	Not relevant	1 Low	2	3	4	5 High
BEFORE this educational activity:	BEFORE this educational activity:: Not relevant	BEFORE this educational activity:: 1 Low	BEFORE this educational activity:: 2	BEFORE this educational activity:: 3	BEFORE this educational activity:: 4	BEFORE this educational activity:: 5 High
AFTER this educational activity:	AFTER this educational activity:: Not relevant	AFTER this educational activity:: 1 Low	AFTER this educational activity:: 2	AFTER this educational activity:: 3	AFTER this educational activity:: 4	AFTER this educational activity:: 5 High

7. Please rate your ABILITY to provide education to patients and peers about the potential benefits and safety concerns related to the use of lentivirus vectors for gene therapy: *This question is required.

Space Cell	Not relevant	1 Low	2	3	4	5 High
BEFORE this educational activity:	BEFORE this educational activity:: Not relevant	BEFORE this educational activity:: 1 Low	BEFORE this educational activity:: 2	BEFORE this educational activity:: 3	BEFORE this educational activity:: 4	BEFORE this educational activity:: 5 High
AFTER this educational activity:	AFTER this educational activity:: Not relevant	AFTER this educational activity:: 1 Low	AFTER this educational activity:: 2	AFTER this educational activity:: 3	AFTER this educational activity:: 4	AFTER this educational activity:: 5 High

*If yes or possibly considering changes, please check off what you intend to do differently or incorporate into your clinical practice as a result of this educational activity. Select all that apply *This question is required.

• Obtain additional information on the potential benefits and safety concerns associated with lentivirus vectors
• Follow current preclinical and clinical studies utilizing the lentivirus for hemophilia gene therapy
• Discuss the differences between AAV and lentivirus vectors for gene therapy with peers and colleagues
• Include the potential of lentivirus vectors in discussions of gene therapy with my patients with hemophilia
• Other - please specify Please enter an 'other' value for this selection.

10. Was the format of this educational activity appropriate for the content presented?  *This question is required.

• Yes
• No

11. Did this educational activity meet your learning needs? *This question is required.

• Yes
• No

13. Was this activity scientifically sound and free of commercial bias or influence?  *This question is required.

• Yes
• No

14. FOR EUROPEAN UNION AND UNITED KINGDOM LEARNERS ONLY:
The France Foundation would like to send you educational opportunities relevant to your practice, emailed to the address you provided. May we have your consent?

• Yes
• No